Diabeloop Unveils New DBLG2 Demo App: Experience the Future of Automated Insulin Delivery Simulation
GRENOBLE, France – July 1, 2026 – Diabeloop, a pioneer in therapeutic AI, today announced the launch of a new, highly anticipated tool: the DBLG2 Demo App. Designed to make the future of diabetes ...
The Centers for Disease Control and Prevention (CDC) state that in the last 20 years, the number of adults diagnosed with diabetes has more than doubled. The primary treatment for type 1 diabetes is ...
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results